Alerts will be sent to your verified email
Verify Email
NGIND
|
NG Industries
|
Tejnaksh Healthcare
|
Aspira Pathlab&Diagn
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
23.44 % | 10.88 % | -17.43 % |
|
5yr average Equity Multiplier
|
1.13 | 1.46 | 1.88 |
|
5yr Average Asset Turnover Ratio
|
0.81 | 0.48 | 0.94 |
|
5yr Avg Net Profit Margin
|
35.6 % | 15.96 % | -7.87 % |
|
Price to Book
|
1.32 | 1.86 | 6.35 |
|
P/E
|
4.56 | 20.46 | 83.44 |
|
5yr Avg Cash Conversion Cycle
|
16.22 Days | -56.42 Days | 0.44 Days |
|
Inventory Days
|
22.11 Days | 20.02 Days | 9.76 Days |
|
Days Receivable
|
2.33 Days | 31.48 Days | 63.31 Days |
|
Days Payable
|
0.0 | 141.3 Days | 71.12 Days |
|
5yr Average Interest Coverage Ratio
|
50.93 | 5.93 | 1.38 |
|
5yr Avg ROCE
|
20.04 % | 13.18 % | 0.39 % |
|
5yr Avg Operating Profit Margin
|
11.77 % | 30.73 % | 7.15 % |
|
5 yr average Debt to Equity
|
0.08 | 0.32 | 0.49 |
|
5yr CAGR Net Profit
|
n/a | -3.16 % | -8.83 % |
|
5yr Average Return on Assets
|
21.18 % | 7.4 % | -2.39 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.5 % | 73.83 % | 18.39 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -17.86 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
NG Industries
|
Tejnaksh Healthcare
|
Aspira Pathlab&Diagn
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|